Stock Code: 000553 (200553) Stock abbreviation: ADAMA A (B) Announcement No. 2025-3
ADAMA Ltd.
2024 Full Year Performance Estimation
The Company and all the directors confirm that the information disclosed herein is true,
accurate, complete and contains no false recording, misleading statement or material omission.
I. Performance Estimation
1. Estimation period: January 1, 2024 - December 31, 2024
2. Estimated performance: net loss
Item Current reporting period Same period last year
January to December January to December
2024 2023
Net loss attributable to the
shareholders of the listed company (3,351)-(2,564) (1,606)
(RMB in millions)
Net loss excluding non-recurring
profits and losses (3,452)-(2,665) (1,851)
(RMB in millions)
Basic earnings per share (1.4384)-(1.1006) (0.6893)
(RMB)
Sales (RMB in millions) 28,014-30,962 32,779
Sales after deduction* (RMB in 28,014-30,962 32,730
millions)
Note: The ‘non-recurring profits and losses’ referred to above are as defined in the Explanatory Announcement No. 1
on Information Disclosure for Companies Offering their Securities to the Public-Non-Recurring Profit and Loss.
* Sales afterdeduction refers to sales after deducting sales unrelated to the main business and sales without commercial
substance
II. Communication with External Auditor
The estimated results of this period are the preliminary estimation of the Company and have not
been audited nor reviewed by certified accountants. The Company and the external auditor have
preliminarily communicated regarding relevant matters of the performance estimation, and have
no material disagreement.
III. Explanations for Performance Variation
Sales
For the full year of 2024, ADAMA is expecting to report a decline in revenues of approximately
6% - 15% in RMB terms (7% - 16% in USD terms), compared to the full year of 2023. The lower
revenues mainly reflect lower prices in 2024, due to just-in-time purchasing patterns of the
channel in light of price volatility and a higher interest rate environment, despite improved channel
inventory levels.
Volumes in Q4 2024 were up compared with Q4 2023 despite the Company’s shift away from
selected low-profit products, marking the second consecutive quarter of volume growth.
EBITDA and Net Loss
In the full year of 2024, the Company is expecting to report a decrease in EBITDA but an increase
in its margin, both in comparison to the full year of 2023. The EBITDA margin increased primarily
due to an increase in the gross margin, mainly reflecting the positive impact of lower costs of new
inventory sold, an improved sales mix towards higher-margin products, and continued control of
operating expenses, all following implementation of the Company's Fight Forward plan, a
strategic transformation plan launched in early 2024 and aimed at gradually delivering improved
profit and cash-targets over a three-year period.
Despite this improvement, the Company is expected to report lower EBITDA and deepened net
loss in the full year of 2024 compared with 2023. The reported financial results are expected to
be affected, in addition to decline in revenue, by net expenses in respect of certain transitory,
non-operational or non-cash items, including mainly:
i. Non-cash amortization charges in respect of Transfer assets received from Syngenta
related to the 2017 ChemChina-Syngenta acquisition;
ii. Non-cash amortization net charges related to intangible assets created as part of the
Purchase Price Allocation (PPA) on acquisitions, with no impact on the ongoing
performance of the companies acquired;
iii. Restructuring costs incurred as part of the implementation of the Fight Forward
transformation plan;
iv. Fixed assets impairment related to improvement of operational efficiency, as part of the
Fight Forward plan;
v. Provisions such as legal claims, registration impairment and update of registration
depreciation;
vi. Soil and water cleanup and remediation;
vii. Financial expenses including non-cash adjustments related to revaluation of put options
attributed to minority stakes in subsidiaries, and expenses deriving from tax claims
surcharges and inflation.
The lower reported operating profit, as a result of above, and a higher tax burden led to deepened
net loss, despite a decrease in financial expenses, in light of lower interest paid on loans, as well
as the net impact of a lower Israeli CPI on the ILS-denominated CPI-linked bonds.
Excluding the impact of the abovementioned transitory, non-operational or
